M4MM

Grown Rogue Reports Q3 2026 Financial Results

MEDFORD – Grown Rogue International Inc. reported higher quarterly revenue and stronger operating cash flow, buoyed by sales growth in New Jersey and tighter cultivation efficiency across its legacy facilities. Yet the craft Cannabis producer ...

Grown Rogue Reports Q3 2026 Financial Results

MEDFORD – Grown Rogue International Inc. reported higher quarterly revenue and stronger operating cash flow, buoyed by sales growth in New Jersey and tighter cultivation efficiency across its legacy facilities. Yet the craft Cannabis producer ...

Planet 13 Reports Q3 2026 Financial Results

LAS VEGAS – Planet 13 Holdings Inc. reported substantially narrower third quarter losses after exiting California and curbing cultivation expenses, even as softer tourism in Las Vegas weighed on overall sales. Total revenue came in ...

SNDL Secures EU-GMP Certification for Atholville Facility

EDMONTON – SNDL Inc. has received European Union Good Manufacturing Practice (EU-GMP) certification for its Atholville, New Brunswick, cultivation facility. The approval authorizes the site to produce and package medical Cannabis flower for regulated international ...

MariMed Reports Q3 2026 Financial Results

NORWOOD – MariMed Inc. reported a record revenue of $44.2 million for the third quarter, up 8.5% from a year earlier and 5.5% from the second quarter. The multustate Cannabis operator beat Wall Street consensus ...

Loud Spectrum Introduces Flower Derived Terpenes

SANTA ANA – Loud Spectrum, a terpene formulator, announced the launch of Flower Derived Terpenes (FDT). The first product, named Alive, is made only from Cannabis flower and extracted within an hour of harvest. The ...

Curaleaf Clears Competition Law Reviews for Aurora Bid

STAMFORD – Curaleaf Holdings Inc. has received every competition law clearance required for its proposed acquisition of Aurora Cannabis Inc. Germany and Canada were the only jurisdictions that required one. On October 20, Germany's Federal ...

Compass Completes FDA Application for COMP360

LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...

Vireo Growth Reports Q3 2026 Financial Results

MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...

Subscribe To Our Newsletter